Last Updated: February 24, 2021    
     


 
Research Featured

Antibody Infusions Prevent Acquisition of Some HIV Strains, NIH Studies Find

HIV.gov | January 26, 2021

Resources from 2020 Conference on Retroviruses and Opportunistic Infections

CROI 2020

HIV postexposure prophylaxis-in-pocket: long-term follow-up of individuals with low-frequency, high-risk HIV exposures

AIDS 2020, 34:433–437

Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or ‘PIP’ (postexposure prophylaxis in-pocket)

AIDS 2020, 34:481–482

News Updates

Therapeutic potential of HIV-1 entry inhibitor peptidomimetics 

Exp Biol Med (Maywood). 2021 Feb 17;1535370221990870. doi: 10.1177/1535370221990870

How activists pushed to include people with HIV in COVID-19 vaccine trials 

ABC News | February 15, 2021

HIV research yields potential drug target 

EurekAlert | February 10, 2021

Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy 

J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):422-429. doi: 10.1097/QAI.0000000000002361.

Novel HIV vaccine approach shows promise in “landmark” first-in-human trial 

European Pharmaceutical Review | February 5, 2021

Phase IIb AMP Studies: In Vitro Susceptibility of HIV-1 Isolates to Broadly Neutralizing Antibody VRC01 Predicts HIV Prevention Efficacy in MSM, Transgender Persons, and Cisgender Women

Clinical Care Options | February 4, 2021

Islatravir Once Monthly for PrEP Demonstrates Favorable Safety/Tolerability and Meets Pharmacokinetic Threshold Target in Blinded Interim Analysis of Phase IIa Trial

Clinical Care Options | February 4, 2021

The Buenos Aires patient: Argentinian woman controls HIV for at least 12 years after stopping treatment

aidsmap | February 3, 2021

Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis 

Front Pharmacol. 2020 Nov 25;11:569373. doi: 10.3389/fphar.2020.569373. eCollection 2020.

‘Gilead Sciences pens early-stage HIV vaccine pact with Gritstone Oncology 

FierceBiotech | February 1, 2021

Labmade antibodies can prevent HIV infection—but only if they match the virus 

Science Magazine | January 26, 2021

Pioneering AIDS researcher and doctor Joseph Sonnabend, 1933-2021 

Thomson Reuters Foundation | January 25, 2021

Emory infectious disease leaders appointed to direct Center for AIDS Research 

Emory News Center | January 19, 2021

Incidence and Clearance of High-Risk HPV in Gay and Bisexual Men 

Infectious Disease Advisor | January 14, 2021

Moderna Pushes Forward With Immunization Development for 3 Infectious Diseases 

Pharmacy Times | January 12, 2021

Study examines attitudes toward long-acting injectable HIV therapy among women 

Science Daily | January 7, 2021

Fiscal Year 2021-2025 NIH Strategic Plan for HIV and HIV-Related Research 

AIDS.gov blog | January 7, 2021

CRISPR Gene-Editing Shows Promise Against HIV 

Managed Healthcare Executive | January 4, 2021

The magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in southern zone Tigray, Ethiopia: a cross-sectional study 

Pan Afr Med J. 2020 Apr 17;35:126. doi: 10.11604/pamj.2020.35.126.17839. eCollection 2020.

Texas Biomed to test CBD/THC against HIV-induced neurological disorder 

EurekAlert | December 11, 2020

Study adapting HIV/AIDS behavioral interventions to mitigate COVID-19 

University of Illinois News | December 8, 2020

NIH announces restructured HIV clinical trials networks

NIH | November 30, 2020

New Hope for HIV Vaccine - Engineered Immune Cells 

Novinite.com | November 21, 2020

Address Medical Mistrust to Recruit Minorities to COVID-19 Trials

Medscape | October 29, 2020

HIV up close: Unprecedented view of virus reveals essential steps for causing AIDS 

Medical Xpress | October 8, 2020

Study Solves an HIV Mystery 

ScienceBlog.com | October 7, 2020

NIH Awards Will Advance HIV Implementation Research in U.S. Communities

HIV.gov | September 29, 2020

Multiple COVID-19 Clusters on a University Campus — North Carolina, August 2020

CDC | September 29, 2020

Recent Increase in COVID-19 Cases Reported Among Adults Aged 18–22 Years — United States, May 31–September 5, 2020

CDC | September 29, 2020

ViiV Healthcare announces start of implementation science study to identify and evaluate approaches to integrating its investigational, every-two-month, injectable HIV treatment in European healthcare practices

ViiV Healthcare | September 28, 2020

$111M Grant to Focus on HIV-Related Cancers [VIDEOS] 

POZ | September 24, 2020

New Long-Acting Injectable HIV Drug Shows Promise in Monkey Study

POZ | September 2, 2020

 
     
    2019 Archives 2020 Archives